Chlorothiazide Sodium
CHLOROTHIAZIDE SODIUM FOR INJECTION, USP
Approved
Approval ID
850960a3-9fe2-4999-81eb-b0ae9ba011bc
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jun 5, 2020
Manufacturers
FDA
American Regent, Inc.
DUNS: 002033710
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Chlorothiazide Sodium
PRODUCT DETAILS
NDC Product Code0517-1820
Application NumberANDA202561
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS
Effective DateJune 5, 2020
Generic NameChlorothiazide Sodium
INGREDIENTS (3)
MANNITOLInactive
Quantity: 250 mg in 18 mL
Code: 3OWL53L36A
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
CHLOROTHIAZIDE SODIUMActive
Quantity: 500 mg in 18 mL
Code: SN86FG7N2K
Classification: ACTIM